Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
NCT04224558Phase 2Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Nov 2019
- Primary completion
- Sep 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous hematopoietic stem cells in Crohn's disease, sponsored by Cedars-Sinai Medical Center. Started Nov 2019; status: recruiting.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04224558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224558.